Subsidiary of ApicHope Pharmaceutical Group (300723.SZ) obtains registration certificate for Injection of New Simec Met.
Statement from Yiping Hong (stock code: 300723.SZ): The company's wholly-owned subsidiary, Guangzhou Lianrui Pharmaceutical Co., Ltd., recently received a notice from the national...
ApicHope Pharmaceutical Group (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Lianrui Pharmaceuticals Co., Ltd. recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the Thiocholine Sulfate Injection.
The Thiocholine Sulfate Injection is indicated for: anticholinesterase drugs. It is used to antagonize the residual muscle relaxation effects of non-depolarizing neuromuscular blocking agents at the end of surgery, as well as for myasthenia gravis, postoperative functional intestinal gas retention, and urinary retention.
Related Articles
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
RECOMMEND
